Loading viewer...
investor_presentation
Format: PDF investor_presentation
Ambu presented 2019/20 financial guidance and product updates including aScope Cysto and aView 2 Advance launches, with aScope Duodeno pending FDA approval. The company upgraded full-year guidance and announced accelerated commercial infrastructure investments of DKK 115m to support new product rollouts.
annual_report
20 Pages
investor_presentation
21 Pages
Jamieson Wellness
investor_presentation
ONE Gas
